{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:48:24Z","timestamp":1760298504466},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/hjh.0b013e3283522a51","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T13:06:52Z","timestamp":1334236012000},"page":"1004-1014","source":"Crossref","is-referenced-by-count":60,"title":["Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial\/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies"],"prefix":"10.1097","volume":"30","author":[{"given":"Paolo","family":"Verdecchia","sequence":"first","affiliation":[]},{"given":"Gilles","family":"Dagenais","sequence":"additional","affiliation":[]},{"given":"Jeff","family":"Healey","sequence":"additional","affiliation":[]},{"given":"Peggy","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Antonio L.","family":"Dans","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Chazova","sequence":"additional","affiliation":[]},{"given":"Azan S.","family":"Binbrek","sequence":"additional","affiliation":[]},{"given":"Gianluca","family":"Iacobellis","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Nicolaas","family":"Holwerda","sequence":"additional","affiliation":[]},{"given":"Nicholas","family":"Karatzas","sequence":"additional","affiliation":[]},{"given":"Matyas","family":"Keltai","sequence":"additional","affiliation":[]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Sleight","sequence":"additional","affiliation":[]},{"given":"Koon","family":"Teo","sequence":"additional","affiliation":[]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-27-20210208","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study.","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"R2-27-20210208","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"R3-27-20210208","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults.","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"R4-27-20210208","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"R5-27-20210208","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"R6-27-20210208","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation.","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"R7-27-20210208","first-page":"134","article-title":"Is obesity a risk factor for atrial fibrillation Nat Clin Pract Cardiovasc M","volume":"2","author":"Iacobellis","year":"2005","journal-title":"ed"},{"key":"R8-27-20210208","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1001\/archinte.166.21.2322","article-title":"Risk of new-onset atrial fibrillation in relation to body mass index.","volume":"166","author":"Dublin","year":"2006","journal-title":"Arch Intern Med"},{"key":"R9-27-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.297.7.709","article-title":"Pulse pressure and risk of new-onset atrial fibrillation.","volume":"297","author":"Mitchell","year":"2007","journal-title":"JAMA"},{"key":"R10-27-20210208","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.0000052830.02773.E4","article-title":"Atrial fibrillation in hypertension: predictors and outcome.","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"R11-27-20210208","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.296.10.1242","article-title":"Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.","volume":"296","author":"Okin","year":"2006","journal-title":"JAMA"},{"key":"R12-27-20210208","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R13-27-20210208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2004.06.080","article-title":"Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R14-27-20210208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0735-1097(98)00221-6","article-title":"Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm.","volume":"32","author":"Pozzoli","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R15-27-20210208","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events.","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-27-20210208","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 4","key":"R17-27-20210208","first-page":"S23","article-title":"Validation of the Omron M5-I blood pressure device according to the international validation protocol.","volume":"21","author":"El Assaad","year":"2003","journal-title":"J Hypertens"},{"key":"R18-27-20210208","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0895-7061(03)00912-9","article-title":"Improved cardiovascular risk stratification by a simple ECG index in hypertension.","volume":"16","author":"Verdecchia","year":"2003","journal-title":"Am J Hypertens"},{"key":"R19-27-20210208","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.109.865774","article-title":"Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.","volume":"120","author":"Verdecchia","year":"2009","journal-title":"Circulation"},{"key":"R20-27-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2307\/2529786","article-title":"An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"R21-27-20210208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and lifetables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"R22-27-20210208","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ajh.2008.248","article-title":"Blood pressure control and risk of incident atrial fibrillation.","volume":"21","author":"Thomas","year":"2008","journal-title":"Am J Hypertens"},{"key":"R23-27-20210208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R24-27-20210208","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"R25-27-20210208","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the RenfrewPaisley study.","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"key":"R26-27-20210208","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ahj.2007.04.062","article-title":"Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.","volume":"154","author":"Salehian","year":"2007","journal-title":"Am Heart J"},{"key":"R27-27-20210208","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis.","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R28-27-20210208","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"R29-27-20210208","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/eurheartj\/ehn324","article-title":"Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years.","volume":"29","author":"Tsang","year":"2008","journal-title":"Eur Heart J"},{"key":"R30-27-20210208","first-page":"2327","article-title":"The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (womens health study).","volume":"2319-","author":"Tedrow","year":"55","journal-title":"J Am Coll Cardiol"},{"key":"R31-27-20210208","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.110.947978","article-title":"Birth weight is a significant risk factor for incident atrial fibrillation.","volume":"122","author":"Conen","year":"2010","journal-title":"Circulation"},{"key":"R32-27-20210208","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study.","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"key":"R33-27-20210208","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ahj.2004.07.009","article-title":"Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.","volume":"149","author":"Dagenais","year":"2005","journal-title":"Am Heart J"},{"key":"R34-27-20210208","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/oby.2003.18","article-title":"Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study.","volume":"11","author":"Snijder","year":"2003","journal-title":"Obes Res"},{"key":"R35-27-20210208","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2796.1997.00235.x","article-title":"Narrow hips and broad waist circumferences independently contribute to increased risk of noninsulin-dependent diabetes mellitus.","volume":"242","author":"Seidell","year":"1997","journal-title":"J Intern Med"},{"key":"R36-27-20210208","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.ijo.0802567","article-title":"Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study.","volume":"28","author":"Snijder","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R37-27-20210208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1568016043356255","article-title":"The adipose tissue as a source of vasoactive factors.","volume":"2","author":"Fruhbeck","year":"2004","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"R38-27-20210208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1467-789X.2006.00257.x","article-title":"Obesity and the heart: redefinition of the relationship.","volume":"8","author":"Iacobellis","year":"2007","journal-title":"Obes Rev"},{"key":"R39-27-20210208","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R40-27-20210208","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjcard.2008.06.018","article-title":"Relation of atrial fibrillation to glomerular filtration rate.","volume":"102","author":"Iguchi","year":"2008","journal-title":"Am J Cardiol"},{"key":"R41-27-20210208","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2003.10.037","article-title":"Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.","volume":"43","author":"Landray","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R42-27-20210208","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.108.830042","article-title":"Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.","volume":"119","author":"Conen","year":"2009","journal-title":"Circulation"},{"key":"R43-27-20210208","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amjcard.2007.09.098","article-title":"Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites.","volume":"101","author":"Novaro","year":"2008","journal-title":"Am J Cardiol"},{"key":"R44-27-20210208","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0027-9684(15)31212-8","article-title":"Racial differences in the prevalence of atrial fibrillation among males.","volume":"100","author":"Borzecki","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"R45-27-20210208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.amjcard.2003.12.004","article-title":"Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study.","volume":"93","author":"Djousse","year":"2004","journal-title":"Am J Cardiol"},{"key":"R46-27-20210208","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation.","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R47-27-20210208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"R48-27-20210208","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction.","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-201205000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T03:34:26Z","timestamp":1713843266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201205000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3283522a51","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}